| Professional Services Industry | Industrials Sector | Ting Zheng CEO | OTC PINK Exchange | G39342103 CUSIP |
| HK Country | 1,202 Employees | 24 Aug 2018 Last Dividend | - Last Split | 9 May 2007 IPO Date |
Global Cord Blood Corporation is a specialized healthcare service provider based in Central, Hong Kong, focusing on the collection, testing, processing, and storage of umbilical cord blood. Serving the People's Republic of China, it operates under the auspices of its parent company, Blue Ocean Structure Investment Company Ltd. Initially known as China Cord Blood Corporation, the organization rebranded to its current name in March 2018, signaling a broader scope of operations. As of March 31, 2022, the company has established a strong operational base with three cord blood banks located in the Beijing municipality, Guangdong province, and Zhejiang province. Through these facilities, Global Cord Blood Corporation offers critical biobanking services, contributing to the health and wellbeing of the Chinese population by facilitating the potential future use of stem cells in medical treatments.
This service involves comprehensive testing of umbilical cord blood to ensure its viability and safety for long-term storage and future medical applications. It is a crucial step in validating the integrity and utility of cord blood, which may contain life-saving stem cells.
The company provides advanced processing services for umbilical cord blood. This process includes cell separation and reduction of plasma volume, which are essential steps in preparing the blood for cryogenic storage, ensuring the preservation of stem cells' functional viability.
Following testing and processing, the company offers long-term, cryogenic storage services for the umbilical cord blood in their state-of-the-art facilities. This service ensures that the stem cells remain viable for decades, available for potential therapeutic use in the future.
Aside from services for individual subscribers, Global Cord Blood Corporation also manages donated cord blood. This involves the testing, processing, and storage of cord blood donated by parents for public use, thus providing a valuable resource for medical research and stem cell transplantation.
In addition to storage services, the company provides matching services wherein they match stored cord blood units with recipients in need of stem cell transplants. This service is vital for those requiring stem cell treatments, facilitating quicker access to compatible stem cells.